249 related articles for article (PubMed ID: 25303852)
1. Physicochemical characterization of epigallocatechin gallate lipid nanoparticles (EGCG-LNs) for ocular instillation.
Fangueiro JF; Andreani T; Fernandes L; Garcia ML; Egea MA; Silva AM; Souto EB
Colloids Surf B Biointerfaces; 2014 Nov; 123():452-60. PubMed ID: 25303852
[TBL] [Abstract][Full Text] [Related]
2. Biopharmaceutical evaluation of epigallocatechin gallate-loaded cationic lipid nanoparticles (EGCG-LNs): In vivo, in vitro and ex vivo studies.
Fangueiro JF; Calpena AC; Clares B; Andreani T; Egea MA; Veiga FJ; Garcia ML; Silva AM; Souto EB
Int J Pharm; 2016 Apr; 502(1-2):161-9. PubMed ID: 26921515
[TBL] [Abstract][Full Text] [Related]
3. Design of cationic lipid nanoparticles for ocular delivery: development, characterization and cytotoxicity.
Fangueiro JF; Andreani T; Egea MA; Garcia ML; Souto SB; Silva AM; Souto EB
Int J Pharm; 2014 Jan; 461(1-2):64-73. PubMed ID: 24275449
[TBL] [Abstract][Full Text] [Related]
4. Design, development, and characterization of lipid nanocarriers-based epigallocatechin gallate delivery system for preventive and therapeutic supplementation.
Frias I; Neves AR; Pinheiro M; Reis S
Drug Des Devel Ther; 2016; 10():3519-3528. PubMed ID: 27826184
[TBL] [Abstract][Full Text] [Related]
5. Comparison of antiproliferative effect of epigallocatechin gallate when loaded into cationic solid lipid nanoparticles against different cell lines.
Silva AM; Martins-Gomes C; Fangueiro JF; Andreani T; Souto EB
Pharm Dev Technol; 2019 Dec; 24(10):1243-1249. PubMed ID: 31437118
[TBL] [Abstract][Full Text] [Related]
6. Encapsulation of biophenolic phytochemical EGCG within lipid nanoparticles enhances its stability and cytotoxicity against cancer.
Radhakrishnan R; Kulhari H; Pooja D; Gudem S; Bhargava S; Shukla R; Sistla R
Chem Phys Lipids; 2016 Jun; 198():51-60. PubMed ID: 27234272
[TBL] [Abstract][Full Text] [Related]
7. Improved anticancer effects of epigallocatechin gallate using RGD-containing nanostructured lipid carriers.
Hajipour H; Hamishehkar H; Nazari Soltan Ahmad S; Barghi S; Maroufi NF; Taheri RA
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):283-292. PubMed ID: 29310467
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial Activity of Epigallocatechin-3-gallate (EGCG) Loaded Lipid-chitosan Hybrid Nanoparticle against Planktonic Microorganisms.
Moreno APD; Marcato PD; Silva LB; Salvador SLS; Arco MCGD; Moraes JCB; Silva RSD; Rossi A
J Oleo Sci; 2024; 73(5):709-716. PubMed ID: 38692893
[TBL] [Abstract][Full Text] [Related]
9. Improving the effectiveness of (-)-epigallocatechin gallate (EGCG) against rabbit atherosclerosis by EGCG-loaded nanoparticles prepared from chitosan and polyaspartic acid.
Hong Z; Xu Y; Yin JF; Jin J; Jiang Y; Du Q
J Agric Food Chem; 2014 Dec; 62(52):12603-9. PubMed ID: 25483592
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic, toxicokinetic, and bioavailability studies of epigallocatechin-3-gallate loaded solid lipid nanoparticle in rat model.
Ramesh N; Mandal AKA
Drug Dev Ind Pharm; 2019 Sep; 45(9):1506-1514. PubMed ID: 31215261
[TBL] [Abstract][Full Text] [Related]
11. Folate-targeted nanostructured lipid carriers for enhanced oral delivery of epigallocatechin-3-gallate.
Granja A; Vieira AC; Chaves LL; Nunes C; Neves AR; Pinheiro M; Reis S
Food Chem; 2017 Dec; 237():803-810. PubMed ID: 28764070
[TBL] [Abstract][Full Text] [Related]
12. pH and temperature stability of (-)-epigallocatechin-3-gallate-β-cyclodextrin inclusion complex-loaded chitosan nanoparticles.
Liu F; Majeed H; Antoniou J; Li Y; Ma Y; Yokoyama W; Ma J; Zhong F
Carbohydr Polym; 2016 Sep; 149():340-7. PubMed ID: 27261758
[TBL] [Abstract][Full Text] [Related]
13. Chitosan nanoparticles enhance the plasma exposure of (-)-epigallocatechin gallate in mice through an enhancement in intestinal stability.
Dube A; Nicolazzo JA; Larson I
Eur J Pharm Sci; 2011 Oct; 44(3):422-6. PubMed ID: 21925598
[TBL] [Abstract][Full Text] [Related]
14. Preparation and optimization of PIT solid lipid nanoparticles via statistical factorial design.
Carbone C; Tomasello B; Ruozi B; Renis M; Puglisi G
Eur J Med Chem; 2012 Mar; 49():110-7. PubMed ID: 22244589
[TBL] [Abstract][Full Text] [Related]
15. Development and evaluation of resveratrol, Vitamin E, and epigallocatechin gallate loaded lipid nanoparticles for skin care applications.
Chen J; Wei N; Lopez-Garcia M; Ambrose D; Lee J; Annelin C; Peterson T
Eur J Pharm Biopharm; 2017 Aug; 117():286-291. PubMed ID: 28411056
[TBL] [Abstract][Full Text] [Related]
16. Nanochemoprevention by encapsulation of (-)-epigallocatechin-3-gallate with bioactive peptides/chitosan nanoparticles for enhancement of its bioavailability.
Hu B; Ting Y; Yang X; Tang W; Zeng X; Huang Q
Chem Commun (Camb); 2012 Feb; 48(18):2421-3. PubMed ID: 22266839
[TBL] [Abstract][Full Text] [Related]
17. Native and thermally modified protein-polyphenol coassemblies: lactoferrin-based nanoparticles and submicrometer particles as protective vehicles for (-)-epigallocatechin-3-gallate.
Yang W; Xu C; Liu F; Yuan F; Gao Y
J Agric Food Chem; 2014 Nov; 62(44):10816-27. PubMed ID: 25310084
[TBL] [Abstract][Full Text] [Related]
18. Epigallocatechin-3-gallate-capped Ag nanoparticles: preparation and characterization.
Hussain S; Khan Z
Bioprocess Biosyst Eng; 2014 Jul; 37(7):1221-31. PubMed ID: 24297160
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of polymeric and lipid nanoparticles of pilocarpine HCl for ocular application.
Lütfi G; Müzeyyen D
Pharm Dev Technol; 2013; 18(3):701-9. PubMed ID: 22813238
[TBL] [Abstract][Full Text] [Related]
20. Formulation parameters influencing the physicochemical characteristics of rosiglitazone-loaded cationic lipid emulsion.
Davaa E; Park JS
Arch Pharm Res; 2012 Jul; 35(7):1205-13. PubMed ID: 22864743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
